Rhabdomyolysis and the Use of Low-Dose Amphetamine

被引:1
|
作者
Swisher, Austin R. [1 ]
Pham, Richard [1 ]
Theodory, Bassam [1 ]
Valiani, Shawn [2 ]
Gowda, Nandini [1 ]
机构
[1] Univ Calif Riverside, Sch Med, Dept Internal Med, Riverside, CA 92521 USA
[2] Calif Univ Sci & Med, Dept Internal Med, Colton, CA USA
关键词
adhd; exercise; amphetamine; dextroamphetamine; rhabdomyolysis; DEFICIT HYPERACTIVITY DISORDER; EXERTIONAL RHABDOMYOLYSIS; ADHD;
D O I
10.7759/cureus.27357
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rhabdomyolysis ranges from being asymptomatic with elevated creatine kinase (CK) to a potentially life-threatening condition involving multiple organ systems. Muscular trauma is the most common cause, followed by enzyme deficiencies, electrolyte abnormalities, drugs, toxins, and endocrinopathies. While these risk factors are delineated, it is not clear if mild exposure to a combination of risk factors could lead to the development of rhabdomyolysis. In this case report, a 22-year-old male of Pakistani/Caucasian ethnicity presented to the emergency room with myalgias and tea-colored urine after starting a new exercise program. His serum CK level and liver function tests were significantly elevated. He was successfully treated for acute rhabdomyolysis with aggressive hydration. However, the etiology of his condition was not clear given that his exercise was not considered vigorous. The only plausible explanation for his symptoms included the use of prescribed dextroamphetamine, which may have exacerbated the physiologic responses induced by exercise. This report describes a novel case in which a patient may have developed recurrent episodes of rhabdomyolysis due to low-dose dextroamphetamine use. The combination of exercise and dextroamphetamine use may predispose patients to develop rhabdomyolysis.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Amphetamine use and sexual practices
    Skarner, Anette
    Svensson, Bengt
    NORDIC STUDIES ON ALCOHOL AND DRUGS, 2013, 30 (05) : 403 - 423
  • [42] Stroke and cocaine or amphetamine use
    Petitti, DB
    Sidney, S
    Quesenberry, C
    Bernstein, A
    EPIDEMIOLOGY, 1998, 9 (06) : 596 - 600
  • [43] NAC Use and/or Abuse in Rhabdomyolysis Patients?
    McCann, Sean
    Bryant, Sean
    CLINICAL TOXICOLOGY, 2020, 58 (11) : 1174 - 1175
  • [44] Pharmacokinetics of AR19, an Immediate-Release Amphetamine Sulfate Formulation Designed to Deter Manipulation for Administration Via Nonoral Routes: Bioequivalence to Reference Racemic Amphetamine Sulfate, Dose Proportionality, and Food Effect
    Caras, Steven
    Sharpe, Terrilyn
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (02) : 69 - 80
  • [45] RHABDOMYOLYSIS SECONDARY TO CLENBUTEROL USE AND EXERCISE
    Grimmer, Nicole M.
    Gimbar, Renee Petzel
    Bursua, Adam
    Patel, Meet
    JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (02) : E71 - E74
  • [46] Surveillance of Diversion and Nonmedical Use of Extended-Release Prescription Amphetamine and Oral Methylphenidate in the United States
    Sembower, Mark A.
    Ertischek, Michelle D.
    Buchholtz, Chloe
    Dasgupta, Nabarun
    Schnoll, Sidney H.
    JOURNAL OF ADDICTIVE DISEASES, 2013, 32 (01) : 26 - 38
  • [47] USE OF AMPHETAMINE IN THE TREATMENT OF APHASIA
    WALKERBATSON, D
    UNWIN, H
    CURTIS, S
    ALLEN, E
    WOOD, M
    SMITH, P
    DEVOUS, MD
    REYNOLDS, S
    GREENLEE, RG
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 1992, 4 (01) : 47 - 50
  • [48] Rhabdomyolysis associated with nutritional supplement use
    Scroggie, DA
    Harris, M
    Sakai, L
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2000, 6 (06) : 328 - 332
  • [49] Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels
    Rupinder Singh Buttar
    Jasveen Batra
    Jacqueline Kreimerman
    Melissa Aleta
    Michal L. Melamed
    Journal of General Internal Medicine, 2017, 32 : 1156 - 1159
  • [50] Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study
    Sikes, Carolyn
    Stark, Jeffrey G.
    McMahen, Russ
    Engelking, Dorothy
    CLINICAL THERAPEUTICS, 2017, 39 (12) : 2389 - 2398